Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net loss $ (201,432) $ (1,402,686)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock based compensation issued to employees 7,742
Stock based compensation - related party   2,390
Depreciation expense 9,360 9,470
Amortization expense 48,890 175,786
Gain on disposal of discontinued operations (260,883)
Accretion of debt discount 27,750 293,740
Change in derivative liabilities (498,963)
Loss on extinguishment of debt   548,425
Amortization of stock issued for future services 11,250
Estimated fair market value of stock issued for services 148,211
Changes in operating assets and liabilities:    
Accounts receivable 8,628
Inventory 31,554 2,545
Prepaid expenses 1,336
Accounts payable (7,594) (61,311)
Due to related party 9,150 380,121
Accrued compensation - related party 195,000 138,750
Deferred revenue (60,839)
Estimated fair value of contingent payments, net (8,931)
Other current liabilities 34,531 5,903
Net cash used in operating activities (113,674) (298,433)
Cash flows from investing activities:    
Acquisition of intangible assets (5,579)
Purchases of computer equipment   (860)
Proceeds from sale of business 100,000
Net cash provided by (used in) investing activities 100,000 (6,439)
Cash flows from financing activities:    
Proceeds from short-term convertible notes, net of debt issuance costs 40,010 250,000
Proceeds from short-term notes, net of debt issuance costs 155,020
Repayments of short term notes (33,333) (101,613)
Net cash provided by financing activities 6,677 303,407
Net decrease in cash (6,997) (1,465)
Cash at beginning of period 7,497 9,592
Cash at end of period 500 8,127
Non-cash investing and financing activities:    
Common stock issued for payment of accounts payable   88,165
Common stock and warrants issued in conjunction with convertible notes payable 169,066
Common stock issued to third party in conjunction with debt issuance 55,500
Warrants issued to third party in conjunction with convertible notes payable 36,739
Debt issuance costs in conjunction with convertible notes payable 44,000
Deferred interest payable issued in conjunction with convertible notes payable 29,400
Reclassification of common stock payable to equity for shares issued $ 156,656